Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Sees Significant Increase in Short Interest

Posted by Alanna Baker on Jan 31st, 2025

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) was the recipient of a significant growth in short interest in January. As of January 15th, there was short interest totalling 4,300 shares, a growth of 207.1% from the December 31st total of 1,400 shares. Based on an average trading volume of 11,200 shares, the days-to-cover ratio is currently 0.4 days.

Invesco Nasdaq Biotechnology ETF Stock Performance

Shares of NASDAQ IBBQ opened at $22.65 on Friday. The company has a market cap of $40.09 million, a PE ratio of 17.39 and a beta of 0.61. The firm’s 50 day moving average price is $22.20 and its 200-day moving average price is $23.25. Invesco Nasdaq Biotechnology ETF has a 52-week low of $20.14 and a 52-week high of $24.84.

Invesco Nasdaq Biotechnology ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Friday, December 27th. Shareholders of record on Monday, December 23rd were issued a $0.0619 dividend. The ex-dividend date was Monday, December 23rd.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. ORG Partners LLC bought a new stake in Invesco Nasdaq Biotechnology ETF in the 3rd quarter worth about $25,000. Strategic Financial Concepts LLC bought a new stake in shares of Invesco Nasdaq Biotechnology ETF in the fourth quarter worth approximately $1,699,000. Finally, Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Invesco Nasdaq Biotechnology ETF by 22.7% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 259,733 shares of the company’s stock worth $6,156,000 after acquiring an additional 48,137 shares during the period.

About Invesco Nasdaq Biotechnology ETF

(Get Free Report)

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.